Literature DB >> 1497405

Clostridium difficile diarrhea induced by cancer chemotherapy.

A G Kamthan1, H W Bruckner, S Z Hirschman, S G Agus.   

Abstract

Four patients had diarrhea due to Clostridium difficile after receiving chemotherapy for cancer. None of the patients had received antibiotics for at least 4 weeks before the onset of diarrhea. At the time of admission of any of these four patients no outbreak of diarrhea was noted on the ward. Each patient was admitted with the acute onset of diarrhea after receiving chemotherapy, at different times of the year. Diarrhea was clinically important and was associated with dehydration, toxemia, and blood in the stool in all cases. Diagnosis of C difficile was confirmed by endoscopic examination, positive biopsy specimen, and positive test for toxin in the stool. All patients recovered after undergoing specific treatment. Drugs not believed to carry serious risk to the bowel mucosa may facilitate proliferation of C difficile. Patients with severe diarrhea after receiving chemotherapy, particularly those with blood in the stool, should be promptly tested for C difficile even in the absence of a history of antibiotic administration. Early and specific treatment can prevent additional morbidity and reduce cost of care.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1497405

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  23 in total

1.  Risks factors and outcomes of Clostridium difficile infection in patients with cancer: a matched case-control study.

Authors:  Andrew I T Hebbard; Monica A Slavin; Caroline Reed; Jason A Trubiano; Benjamin W Teh; Gabrielle M Haeusler; Karin A Thursky; Leon J Worth
Journal:  Support Care Cancer       Date:  2017-02-02       Impact factor: 3.603

Review 2.  Physical, Laboratory, Radiographic, and Endoscopic Workup for Clostridium difficile Colitis.

Authors:  Samantha J Baker; Daniel I Chu
Journal:  Clin Colon Rectal Surg       Date:  2020-02-25

3.  Postoperative Clostridium difficile-associated diarrhea.

Authors:  William N Southern; Rabin Rahmani; Olga Aroniadis; Igal Khorshidi; Andy Thanjan; Christopher Ibrahim; Lawrence J Brandt
Journal:  Surgery       Date:  2010-02-08       Impact factor: 3.982

4.  Clostridium difficile infection in fever patients with gynecological malignancies.

Authors:  Shintaro Yanazume; Akio Tokudome; Mika Fukuda; Shinichi Togami; Masaki Kamio; Shunichiro Ota; Hiroaki Kobayashi
Journal:  Cancer Rep (Hoboken)       Date:  2019-07-22

5.  Prognosis of Clostridium difficile infection in adult oncohaematological patients: experience from a large prospective observational study.

Authors:  Isabel Ruiz-Camps; Benito Almirante; Thais Larrainzar-Coghen; Dolors Rodríguez-Pardo; Pere Barba; Juan Aguilar-Company; Virginia Rodríguez; Gloria Roig; Carmen Ferrer
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-08-02       Impact factor: 3.267

6.  Molecular epidemiology of hospital-associated and community-acquired Clostridium difficile infection in a Swedish county.

Authors:  T Norén; T Akerlund; E Bäck; L Sjöberg; I Persson; I Alriksson; L G Burman
Journal:  J Clin Microbiol       Date:  2004-08       Impact factor: 5.948

7.  Investigation of an outbreak of Clostridium difficile infection in a general hospital by numerical analysis of protein patterns by sodium dodecyl sulfate-polyacrylamide gel electrophoresis.

Authors:  M Costas; B Holmes; S L On; M Ganner; M C Kelly; S K Nath
Journal:  J Clin Microbiol       Date:  1994-03       Impact factor: 5.948

8.  Impact of malignancy on Clostridium difficile infection.

Authors:  M S Chung; J Kim; J O Kang; H Pai
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-07-26       Impact factor: 3.267

Review 9.  Ipilimumab-Induced Enterocolitis: A Systematic Review and Meta-Analysis.

Authors:  Kelcie Witges; Leigh Anne Shafer; Ryan Zarychanski; Ahmed M Abou-Setta; Rasheda Rabbani; Orvie Dingwall; Charles N Bernstein
Journal:  Drug Saf       Date:  2020-12       Impact factor: 5.606

Review 10.  The role of surgery in pseudomembranous enterocolitis.

Authors:  Y K Viswanath; C D Griffiths
Journal:  Postgrad Med J       Date:  1998-04       Impact factor: 2.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.